Respiratory Syncytial Virus Market Outlook Scope and Overview: The Respiratory Syncytial Virus (RSV) Therapeutics Market, valued at USD 5.75 billion in 2023, is set for significant expansion over the next several years. By 2031, the market is projected to reach USD 15.28 billion, growing at a compound annual growth rate (CAGR) of 13% from 2024 to 2031. RSV, a major cause of...